Key result
Melatonin plus NMN improves post-ischemic hemodynamics and curbs myocardial injury in aged rats.
Why the study?
Does the combination of melatonin and nicotinamide mononucleotide improve isolated heart hemodynamic function and reduce myocardial injury and inflammation compared to monotherapy or untreated control in aged rats subjected to ischemia-reperfusion injury?
Does the combination of melatonin and nicotinamide mononucleotide improve isolated heart hemodynamic function and reduce myocardial injury and inflammation compared to monotherapy or untreated control in aged rats subjected to ischemia-reperfusion injury?
In an isolated aged rat heart model, combined administration of melatonin and nicotinamide mononucleotide provides additive cardioprotection against ischemia-reperfusion injury by improving left ventricular hemodynamics and reducing myocardial creatine kinase release and inflammatory cytokine expression.
Answers are grounded in this paper and cite their sources.
Should not yet inform clinical ischemia-reperfusion management; leaves open additive cardioprotection of combined therapy in aged models.
every other day for 28 days. Creatine kinase and inflammatory markers, including interleukin IL-1β, IL-6, tumor necrosis factor-alpha, and nuclear factor kappa B, were also assessed. IR significantly impaired coronary flow and heart rate, both of which were improved by M and N treatment. These agents also reduced left ventricular end-diastolic pressure and improved left ventricular developed pressure recovery, with the combined therapy producing the greatest effect. Likewise, creatine kinase and inflammatory marker levels were significantly elevated in the IR group but markedly reduced by treatment, especially by combined administration. These findings suggest that M and N exert additive cardioprotective effects against IR injury in aged rats.
No takes yet. Share an insight, caveat, or question.
Amanzadeh et al. (2026) studied Myocardial ischemia-reperfusion injury (n=40). Melatonin and nicotinamide mononucleotide (NMN) vs. Untreated ischemia-reperfusion (IR) control, Sham, or monotherapy (Melatonin alone or NMN alone) was evaluated on Hemodynamic recovery (LVEDP, LVDP), myocardial injury (creatine kinase release), and myocardial inflammatory marker expression (IL-1β, IL-6, TNF-α, NF-κB) (p=<0.001). Combined melatonin and nicotinamide mononucleotide improved hemodynamic recovery and reduced creatine kinase and inflammatory markers after ischemia-reperfusion in aged rats.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: